Very quickly SusannB before I do something more productive.
Market forces can create a recklessness in drug development. Shareholders love their micro-cap biotech company moving into P3 where the rubber hits the road.
Very different incentives can exist between small companies and big pharma.
In big pharma the aim is to fail as quickly and as cheaply as possible. Because pursuing things into P3 and failing makes a big dent in the profit line.
For little pharma there is no profit bottom line. You just raise more money from shareholders; admittedly at lower prices the longer things go on for.
- Forums
- ASX - By Stock
- MSB
- Ann: Half Year Report and Accounts (including Appendix 4D)
Ann: Half Year Report and Accounts (including Appendix 4D), page-245
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 43578 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 31763 | 1.100 |
2 | 33264 | 1.090 |
2 | 18897 | 1.085 |
2 | 18926 | 1.080 |
1 | 18000 | 1.075 |
Price($) | Vol. | No. |
---|---|---|
1.130 | 23400 | 3 |
1.135 | 1090 | 1 |
1.140 | 65000 | 4 |
1.145 | 64500 | 3 |
1.150 | 92314 | 9 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |